Ltd.;Research Institute for Nutrition and Aging Co.;RES INSTITUTE FOR NUTRITION AND AGING CO LTD
发明人:
申请号：
EP14732025.3
公开号：
EP3003296B1
申请日:
2014.05.23
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Provided is a novel medicament capable of reducing the side effects of metformin or a pharmaceutically acceptable salt thereof and useful as an anti-malignant tumor agent, in which metformin or a pharmaceutically acceptable salt thereof and dihydroquercetin or a pharmaceutically acceptable salt thereof are combined.
